March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback